ID ESTA_BACSU Reviewed; 212 AA. AC P37957; O34644; Q2XU59; DT 01-OCT-1994, integrated into UniProtKB/Swiss-Prot. DT 30-MAY-2000, sequence version 2. DT 27-MAR-2024, entry version 154. DE RecName: Full=Lipase EstA; DE AltName: Full=Lipase A; DE EC=3.1.1.3 {ECO:0000269|PubMed:11029590, ECO:0000269|PubMed:8396026}; DE AltName: Full=Triacylglycerol lipase; DE Flags: Precursor; GN Name=estA; GN Synonyms=lip {ECO:0000303|PubMed:1320940}, lipA GN {ECO:0000303|PubMed:11029590}; OrderedLocusNames=BSU02700; OS Bacillus subtilis (strain 168). OC Bacteria; Bacillota; Bacilli; Bacillales; Bacillaceae; Bacillus. OX NCBI_TaxID=224308; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION. RC STRAIN=168; RX PubMed=1320940; DOI=10.1016/0167-4781(92)90023-s; RA Dartois V., Baulard A., Schanck K., Colson C.; RT "Cloning, nucleotide sequence and expression in Escherichia coli of a RT lipase gene from Bacillus subtilis 168."; RL Biochim. Biophys. Acta 1131:253-260(1992). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=168; RX PubMed=9274031; DOI=10.1099/00221287-143-8-2775; RA Kumano M., Tamakoshi A., Yamane K.; RT "A 32 kb nucleotide sequence from the region of the lincomycin-resistance RT gene (22 degrees-25 degrees) of the Bacillus subtilis chromosome and RT identification of the site of the lin-2 mutation."; RL Microbiology 143:2775-2782(1997). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RA Peerzada K., Johri S., Rasool S., Qazi G.N.; RT "Molecular characterization of a lipase from a strain of Bacillus RT subtilis."; RL Submitted (OCT-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=168; RX PubMed=9384377; DOI=10.1038/36786; RA Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G., Azevedo V., RA Bertero M.G., Bessieres P., Bolotin A., Borchert S., Borriss R., RA Boursier L., Brans A., Braun M., Brignell S.C., Bron S., Brouillet S., RA Bruschi C.V., Caldwell B., Capuano V., Carter N.M., Choi S.-K., RA Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A., Denizot F., RA Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T., Entian K.-D., RA Errington J., Fabret C., Ferrari E., Foulger D., Fritz C., Fujita M., RA Fujita Y., Fuma S., Galizzi A., Galleron N., Ghim S.-Y., Glaser P., RA Goffeau A., Golightly E.J., Grandi G., Guiseppi G., Guy B.J., Haga K., RA Haiech J., Harwood C.R., Henaut A., Hilbert H., Holsappel S., Hosono S., RA Hullo M.-F., Itaya M., Jones L.-M., Joris B., Karamata D., Kasahara Y., RA Klaerr-Blanchard M., Klein C., Kobayashi Y., Koetter P., Koningstein G., RA Krogh S., Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J., RA Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C., RA Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S., RA Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B., RA Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S., RA Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G., Rey M., RA Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B., Rose M., Sadaie Y., RA Sato T., Scanlan E., Schleich S., Schroeter R., Scoffone F., Sekiguchi J., RA Sekowska A., Seror S.J., Serror P., Shin B.-S., Soldo B., Sorokin A., RA Tacconi E., Takagi T., Takahashi H., Takemaru K., Takeuchi M., RA Tamakoshi A., Tanaka T., Terpstra P., Tognoni A., Tosato V., Uchiyama S., RA Vandenbol M., Vannier F., Vassarotti A., Viari A., Wambutt R., Wedler E., RA Wedler H., Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K., RA Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E., RA Yoshikawa H., Danchin A.; RT "The complete genome sequence of the Gram-positive bacterium Bacillus RT subtilis."; RL Nature 390:249-256(1997). RN [5] RP FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL RP PROPERTIES, SUBCELLULAR LOCATION, INDUCTION, AND N-TERMINAL END. RC STRAIN=168; RX PubMed=8396026; DOI=10.1111/j.1432-1033.1993.tb18127.x; RA Lesuisse E., Schanck K., Colson C.; RT "Purification and preliminary characterization of the extracellular lipase RT of Bacillus subtilis 168, an extremely basic pH-tolerant enzyme."; RL Eur. J. Biochem. 216:155-160(1993). RN [6] RP FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, AND BIOPHYSICOCHEMICAL RP PROPERTIES. RC STRAIN=168 / BCL 1050; RX PubMed=11029590; DOI=10.1046/j.1432-1327.2000.01736.x; RA Eggert T., Pencreac'h G., Douchet I., Verger R., Jaeger K.-E.; RT "A novel extracellular esterase from Bacillus subtilis and its conversion RT to a monoacylglycerol hydrolase."; RL Eur. J. Biochem. 267:6459-6469(2000). RN [7] RP PROBABLE ACTIVE SITE, SUBCELLULAR LOCATION, AND INDUCTION. RC STRAIN=168 / BCL 1050; RX PubMed=11583117; DOI=10.1016/s0014-5793(01)02665-5; RA Eggert T., van Pouderoyen G., Dijkstra B.W., Jaeger K.-E.; RT "Lipolytic enzymes LipA and LipB from Bacillus subtilis differ in RT regulation of gene expression, biochemical properties, and three- RT dimensional structure."; RL FEBS Lett. 502:89-92(2001). RN [8] {ECO:0007744|PDB:1I6W} RP X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 32-212, PROBABLE ACTIVE SITE, AND RP PROBABLE SUBUNIT. RC STRAIN=168; RX PubMed=11491291; DOI=10.1006/jmbi.2001.4659; RA van Pouderoyen G., Eggert T., Jaeger K.-E., Dijkstra B.W.; RT "The crystal structure of Bacillus subtilis lipase: a minimal alpha/beta RT hydrolase fold enzyme."; RL J. Mol. Biol. 309:215-226(2001). RN [9] {ECO:0007744|PDB:1ISP} RP X-RAY CRYSTALLOGRAPHY (1.3 ANGSTROMS) OF 32-212, PROBABLE ACTIVE SITE, AND RP SUBUNIT. RC STRAIN=168; RX PubMed=12077437; DOI=10.1107/s090744490200714x; RA Kawasaki K., Kondo H., Suzuki M., Ohgiya S., Tsuda S.; RT "Alternate conformations observed in catalytic serine of Bacillus subtilis RT lipase determined at 1.3 A resolution."; RL Acta Crystallogr. D 58:1168-1174(2002). CC -!- FUNCTION: Active toward triacylglycerides with a preference for esters CC with C8:0 acyl groups; barely active on C18:1 or C18:4 substrates. CC Active against p-nitrophenylesters with fatty acid chain lengths from CC C6 to C18. {ECO:0000269|PubMed:11029590, ECO:0000269|PubMed:8396026, CC ECO:0000305|PubMed:1320940}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a triacylglycerol + H2O = a diacylglycerol + a fatty acid + CC H(+); Xref=Rhea:RHEA:12044, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:17855, ChEBI:CHEBI:18035, ChEBI:CHEBI:28868; EC=3.1.1.3; CC Evidence={ECO:0000269|PubMed:11029590, ECO:0000269|PubMed:8396026}; CC -!- ACTIVITY REGULATION: Strongly inhibited when incubated with the serine CC reagent phenylmethylsulfonyl fluoride. Activated by the addition of CC calcium to the reaction mixture. When calcium was incubated with the CC lipase but not added to the reaction mixture, its effect is lower but CC still observable. Magnesium, manganese and strontium are not able to CC replace calcium with full retention of activity. CC {ECO:0000269|PubMed:8396026}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC pH dependence: CC Optimum pH is 10 (PubMed:11029590). The activity decreases strongly CC above pH 10.5 or below pH 6.5. The enzyme is remarkably stable at CC alkaline pH, showing maximum stability at pH 12 and retaining more CC than 65% of its activity after 24 hours at pH 13 (PubMed:8396026). CC {ECO:0000269|PubMed:11029590, ECO:0000269|PubMed:8396026}; CC Temperature dependence: CC Optimum temperature is 35 degrees Celsius. Stable for at least 30 CC minutes at 40 degrees Celsius. Virtually no activity remains after 30 CC minutes at 55 degrees Celsius. {ECO:0000269|PubMed:11029590, CC ECO:0000269|PubMed:8396026}; CC -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:11491291, CC ECO:0000269|PubMed:12077437}. CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:11583117, CC ECO:0000269|PubMed:8396026}. CC -!- INDUCTION: Maximally expressed in late exponential growth phase. CC Expression decreases rapidly in the stationary phase. Expressed in both CC rich and minimal media with glucose as carbon source (at protein CC level). {ECO:0000269|PubMed:11583117, ECO:0000269|PubMed:8396026}. CC -!- SIMILARITY: Belongs to the AB hydrolase superfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M74010; AAA22574.1; -; Genomic_DNA. DR EMBL; AB000617; BAA22231.1; -; Genomic_DNA. DR EMBL; DQ250714; ABB54395.1; -; Genomic_DNA. DR EMBL; AL009126; CAB12064.1; -; Genomic_DNA. DR PIR; S23934; S23934. DR RefSeq; NP_388152.1; NC_000964.3. DR RefSeq; WP_003246250.1; NZ_JNCM01000030.1. DR PDB; 1I6W; X-ray; 1.50 A; A/B=32-212. DR PDB; 1ISP; X-ray; 1.30 A; A=32-212. DR PDB; 1R4Z; X-ray; 1.80 A; A/B=32-212. DR PDB; 1R50; X-ray; 1.45 A; A/B=32-212. DR PDB; 1T2N; X-ray; 1.80 A; A=32-212. DR PDB; 1T4M; X-ray; 2.00 A; A=32-212. DR PDB; 2QXT; X-ray; 2.00 A; A/B=34-212. DR PDB; 2QXU; X-ray; 1.90 A; A/B/C/D/E/F/G/H=34-212. DR PDB; 3D2A; X-ray; 1.73 A; A=32-212. DR PDB; 3D2B; X-ray; 1.95 A; A/B=32-212. DR PDB; 3D2C; X-ray; 2.18 A; A/B/C/D/E/F/G/H/I/J/K/L=32-212. DR PDB; 3QMM; X-ray; 1.89 A; A/B=32-212. DR PDB; 3QZU; X-ray; 1.85 A; A/B=32-212. DR PDB; 5CRI; X-ray; 1.63 A; A/B=32-212. DR PDB; 5CT4; X-ray; 1.49 A; A/B=33-212. DR PDB; 5CT5; X-ray; 1.75 A; A/B=33-212. DR PDB; 5CT6; X-ray; 1.90 A; A/B=33-212. DR PDB; 5CT8; X-ray; 1.29 A; A=33-212. DR PDB; 5CT9; X-ray; 1.40 A; A=33-212. DR PDB; 5CTA; X-ray; 1.24 A; A=33-212. DR PDB; 5CUR; X-ray; 1.30 A; A=33-212. DR PDBsum; 1I6W; -. DR PDBsum; 1ISP; -. DR PDBsum; 1R4Z; -. DR PDBsum; 1R50; -. DR PDBsum; 1T2N; -. DR PDBsum; 1T4M; -. DR PDBsum; 2QXT; -. DR PDBsum; 2QXU; -. DR PDBsum; 3D2A; -. DR PDBsum; 3D2B; -. DR PDBsum; 3D2C; -. DR PDBsum; 3QMM; -. DR PDBsum; 3QZU; -. DR PDBsum; 5CRI; -. DR PDBsum; 5CT4; -. DR PDBsum; 5CT5; -. DR PDBsum; 5CT6; -. DR PDBsum; 5CT8; -. DR PDBsum; 5CT9; -. DR PDBsum; 5CTA; -. DR PDBsum; 5CUR; -. DR AlphaFoldDB; P37957; -. DR BMRB; P37957; -. DR SMR; P37957; -. DR STRING; 224308.BSU02700; -. DR DrugBank; DB08475; [(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl hydrogen hex-5-enylphosphonate. DR DrugBank; DB08548; [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl hydrogen hex-5-enylphosphonate. DR ESTHER; bacsu-lip; Lipase_2. DR PaxDb; 224308-BSU02700; -. DR EnsemblBacteria; CAB12064; CAB12064; BSU_02700. DR GeneID; 938389; -. DR KEGG; bsu:BSU02700; -. DR PATRIC; fig|224308.179.peg.280; -. DR eggNOG; COG1075; Bacteria. DR InParanoid; P37957; -. DR OrthoDB; 503948at2; -. DR PhylomeDB; P37957; -. DR BioCyc; BSUB:BSU02700-MONOMER; -. DR SABIO-RK; P37957; -. DR EvolutionaryTrace; P37957; -. DR Proteomes; UP000001570; Chromosome. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell. DR GO; GO:0016298; F:lipase activity; IBA:GO_Central. DR GO; GO:0004806; F:triglyceride lipase activity; IDA:CACAO. DR GO; GO:0016042; P:lipid catabolic process; IBA:GO_Central. DR Gene3D; 3.40.50.1820; alpha/beta hydrolase; 1. DR InterPro; IPR029058; AB_hydrolase. DR InterPro; IPR002918; Lipase_EstA/Esterase_EstB. DR PANTHER; PTHR32015; FASTING INDUCED LIPASE; 1. DR PANTHER; PTHR32015:SF1; FASTING INDUCED LIPASE; 1. DR Pfam; PF01674; Lipase_2; 1. DR SUPFAM; SSF53474; alpha/beta-Hydrolases; 1. PE 1: Evidence at protein level; KW 3D-structure; Hydrolase; Lipid degradation; Lipid metabolism; KW Reference proteome; Secreted; Signal. FT SIGNAL 1..31 FT /evidence="ECO:0000305|PubMed:8396026" FT CHAIN 32..212 FT /note="Lipase EstA" FT /id="PRO_0000017819" FT ACT_SITE 108 FT /note="Nucleophile" FT /evidence="ECO:0000305|PubMed:11491291, FT ECO:0000305|PubMed:11583117, ECO:0000305|PubMed:12077437" FT ACT_SITE 164 FT /note="Charge relay system" FT /evidence="ECO:0000305|PubMed:11491291, FT ECO:0000305|PubMed:11583117, ECO:0000305|PubMed:12077437" FT ACT_SITE 187 FT /note="Charge relay system" FT /evidence="ECO:0000305|PubMed:11491291, FT ECO:0000305|PubMed:11583117, ECO:0000305|PubMed:12077437" FT CONFLICT 29 FT /note="A -> V (in Ref. 3; ABB54395)" FT /evidence="ECO:0000305" FT CONFLICT 51 FT /note="A -> G (in Ref. 3; ABB54395)" FT /evidence="ECO:0000305" FT CONFLICT 60 FT /note="Q -> H (in Ref. 3; ABB54395)" FT /evidence="ECO:0000305" FT CONFLICT 133 FT /note="L -> V (in Ref. 1; AAA22574 and 3; ABB54395)" FT /evidence="ECO:0000305" FT STRAND 37..40 FT /evidence="ECO:0007829|PDB:5CTA" FT HELIX 47..50 FT /evidence="ECO:0007829|PDB:5CTA" FT HELIX 51..59 FT /evidence="ECO:0007829|PDB:5CTA" FT HELIX 64..66 FT /evidence="ECO:0007829|PDB:5CTA" FT STRAND 67..69 FT /evidence="ECO:0007829|PDB:5CTA" FT HELIX 79..97 FT /evidence="ECO:0007829|PDB:5CTA" FT STRAND 102..107 FT /evidence="ECO:0007829|PDB:5CTA" FT HELIX 110..120 FT /evidence="ECO:0007829|PDB:5CTA" FT HELIX 123..125 FT /evidence="ECO:0007829|PDB:5CTA" FT STRAND 127..134 FT /evidence="ECO:0007829|PDB:5CTA" FT HELIX 137..139 FT /evidence="ECO:0007829|PDB:5CTA" FT STRAND 155..161 FT /evidence="ECO:0007829|PDB:5CTA" FT STRAND 165..167 FT /evidence="ECO:0007829|PDB:5CTA" FT HELIX 169..172 FT /evidence="ECO:0007829|PDB:5CTA" FT STRAND 177..184 FT /evidence="ECO:0007829|PDB:5CTA" FT HELIX 189..191 FT /evidence="ECO:0007829|PDB:5CTA" FT HELIX 194..204 FT /evidence="ECO:0007829|PDB:5CTA" FT TURN 205..207 FT /evidence="ECO:0007829|PDB:5CTA" SQ SEQUENCE 212 AA; 22791 MW; B8A70E027461188F CRC64; MKFVKRRIIA LVTILMLSVT SLFALQPSAK AAEHNPVVMV HGIGGASFNF AGIKSYLVSQ GWSRDKLYAV DFWDKTGTNY NNGPVLSRFV QKVLDETGAK KVDIVAHSMG GANTLYYIKN LDGGNKVANV VTLGGANRLT TGKALPGTDP NQKILYTSIY SSADMIVMNY LSRLDGARNV QIHGVGHIGL LYSSQVNSLI KEGLNGGGQN TN //